BR9506098A - Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo - Google Patents
Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativoInfo
- Publication number
- BR9506098A BR9506098A BR9506098A BR9506098A BR9506098A BR 9506098 A BR9506098 A BR 9506098A BR 9506098 A BR9506098 A BR 9506098A BR 9506098 A BR9506098 A BR 9506098A BR 9506098 A BR9506098 A BR 9506098A
- Authority
- BR
- Brazil
- Prior art keywords
- prevent
- active compound
- optically active
- osteogenesis
- promoter
- Prior art date
Links
- 208000020084 Bone disease Diseases 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 2
- 230000011164 ossification Effects 0.000 title 2
- 208000010392 Bone Fractures Diseases 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 230000035876 healing Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
- C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32727594 | 1994-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9506098A true BR9506098A (pt) | 1997-12-23 |
Family
ID=18197308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9506098A BR9506098A (pt) | 1994-12-28 | 1995-12-27 | Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6346521B1 (pt) |
| EP (1) | EP0719782B1 (pt) |
| KR (1) | KR960022542A (pt) |
| CN (1) | CN1058718C (pt) |
| AR (1) | AR002018A1 (pt) |
| AT (1) | ATE202782T1 (pt) |
| AU (1) | AU689004B2 (pt) |
| BR (1) | BR9506098A (pt) |
| CA (1) | CA2166152A1 (pt) |
| DE (1) | DE69521595T2 (pt) |
| DK (1) | DK0719782T3 (pt) |
| ES (1) | ES2158034T3 (pt) |
| FI (1) | FI956273A (pt) |
| GR (1) | GR3036757T3 (pt) |
| HU (1) | HUT74562A (pt) |
| NO (1) | NO303641B1 (pt) |
| NZ (1) | NZ280745A (pt) |
| PT (1) | PT719782E (pt) |
| RU (1) | RU2162083C2 (pt) |
| TW (1) | TW403757B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5910492A (en) * | 1995-06-05 | 1999-06-08 | Takeda Chemical Industries, Ltd. | Osteogenic promoting pharmaceutical composition |
| WO1996039134A1 (en) * | 1995-06-05 | 1996-12-12 | Takeda Chemical Industries, Ltd. | Osteogenetic promoting pharmaceutical composition |
| AU6471896A (en) * | 1995-07-24 | 1997-02-18 | Takeda Chemical Industries Ltd. | Production of optically active benzothiepin salts |
| AU3868997A (en) * | 1996-08-26 | 1998-03-19 | Takeda Chemical Industries Ltd. | Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
| AU4571097A (en) * | 1996-10-09 | 1998-05-05 | Takeda Chemical Industries Ltd. | A method for producing a microparticle |
| EP1087774A2 (en) * | 1998-06-15 | 2001-04-04 | Takeda Chemical Industries, Ltd. | Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds |
| EP1103552A4 (en) | 1998-08-07 | 2003-01-15 | Takeda Chemical Industries Ltd | BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE |
| WO2000009100A2 (en) * | 1998-08-12 | 2000-02-24 | Takeda Chemical Industries, Ltd. | Benzothiepine compounds as enhancer of cell differentiation induction factor |
| AU5998799A (en) * | 1998-09-30 | 2000-04-17 | Takeda Chemical Industries Ltd. | Bone repair materials/artificial bone compositions |
| US6794544B2 (en) * | 2000-03-10 | 2004-09-21 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
| CA2454200A1 (en) * | 2001-07-17 | 2003-01-30 | Teva Pharmaceutical Industries Ltd. | Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| US20050026871A1 (en) * | 2002-07-17 | 2005-02-03 | Moshe Flashner-Barak | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative |
| EP1640010A1 (en) * | 2003-07-01 | 2006-03-29 | Astellas Pharma Inc. | Agent inducing increase in bone mass |
| WO2009006226A1 (en) * | 2007-06-29 | 2009-01-08 | Kci Licensing Inc. | Activation of bone and cartilage formation |
| EP2380878B1 (en) | 2009-01-19 | 2013-08-14 | Daiichi Sankyo Company, Limited | Cyclic compound having hetero atom |
| KR20120006016A (ko) | 2009-04-06 | 2012-01-17 | 다이이찌 산쿄 가부시키가이샤 | 치환 페닐기를 갖는 고리형 화합물 |
| AU2011246067A1 (en) | 2010-04-28 | 2012-09-27 | Daiichi Sankyo Company, Limited | [5,6] heterocyclic compound |
| WO2015030189A1 (ja) | 2013-08-29 | 2015-03-05 | 京都薬品工業株式会社 | 新規芳香族化合物およびその用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5158943A (en) * | 1988-11-21 | 1992-10-27 | Takeda Chemical Industries, Ltd. | Sulfur-containing heterocyclic compounds |
| DK656789A (da) * | 1988-12-28 | 1990-06-29 | Takeda Chemical Industries Ltd | Benzoheterocykliske forbindelser |
| DK0460488T3 (da) * | 1990-05-30 | 2001-09-17 | Takeda Chemical Industries Ltd | Svovlholdige heterocykliske forbindelser |
| JP3165866B2 (ja) * | 1990-06-06 | 2001-05-14 | 武田薬品工業株式会社 | 含硫黄複素環化合物 |
-
1995
- 1995-12-20 TW TW084113629A patent/TW403757B/zh not_active IP Right Cessation
- 1995-12-21 NZ NZ280745A patent/NZ280745A/en unknown
- 1995-12-22 DK DK95120444T patent/DK0719782T3/da active
- 1995-12-22 AT AT95120444T patent/ATE202782T1/de not_active IP Right Cessation
- 1995-12-22 AU AU40693/95A patent/AU689004B2/en not_active Ceased
- 1995-12-22 PT PT95120444T patent/PT719782E/pt unknown
- 1995-12-22 EP EP95120444A patent/EP0719782B1/en not_active Expired - Lifetime
- 1995-12-22 DE DE69521595T patent/DE69521595T2/de not_active Expired - Fee Related
- 1995-12-22 ES ES95120444T patent/ES2158034T3/es not_active Expired - Lifetime
- 1995-12-27 CA CA002166152A patent/CA2166152A1/en not_active Abandoned
- 1995-12-27 BR BR9506098A patent/BR9506098A/pt unknown
- 1995-12-27 NO NO955305A patent/NO303641B1/no not_active IP Right Cessation
- 1995-12-27 HU HU9503802A patent/HUT74562A/hu unknown
- 1995-12-27 RU RU95122478/04A patent/RU2162083C2/ru active
- 1995-12-27 FI FI956273A patent/FI956273A/fi unknown
- 1995-12-28 US US08/579,731 patent/US6346521B1/en not_active Expired - Fee Related
- 1995-12-28 CN CN95121715A patent/CN1058718C/zh not_active Expired - Fee Related
- 1995-12-28 AR ARP950100805A patent/AR002018A1/es unknown
- 1995-12-28 KR KR1019950061545A patent/KR960022542A/ko not_active Application Discontinuation
-
2000
- 2000-08-09 US US09/635,067 patent/US6632807B1/en not_active Expired - Fee Related
-
2001
- 2001-09-28 GR GR20010401614T patent/GR3036757T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69521595T2 (de) | 2002-05-23 |
| PT719782E (pt) | 2001-10-31 |
| CA2166152A1 (en) | 1996-06-29 |
| CN1131669A (zh) | 1996-09-25 |
| NO955305D0 (no) | 1995-12-27 |
| RU2162083C2 (ru) | 2001-01-20 |
| EP0719782B1 (en) | 2001-07-04 |
| NZ280745A (en) | 1997-09-22 |
| FI956273A (fi) | 1996-06-29 |
| AU4069395A (en) | 1996-07-04 |
| ES2158034T3 (es) | 2001-09-01 |
| US6346521B1 (en) | 2002-02-12 |
| CN1058718C (zh) | 2000-11-22 |
| NO303641B1 (no) | 1998-08-10 |
| US6632807B1 (en) | 2003-10-14 |
| KR960022542A (ko) | 1996-07-18 |
| FI956273A0 (fi) | 1995-12-27 |
| GR3036757T3 (en) | 2001-12-31 |
| EP0719782A1 (en) | 1996-07-03 |
| AU689004B2 (en) | 1998-03-19 |
| HU9503802D0 (en) | 1996-02-28 |
| NO955305L (no) | 1996-07-01 |
| AR002018A1 (es) | 1998-01-07 |
| ATE202782T1 (de) | 2001-07-15 |
| DK0719782T3 (da) | 2001-09-24 |
| DE69521595D1 (de) | 2001-08-09 |
| HUT74562A (en) | 1997-01-28 |
| TW403757B (en) | 2000-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9506098A (pt) | Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo | |
| BR8900948A (pt) | Composicao aquosa condicionadora de tecidos e processo para tratamento de tecidos | |
| FI954654A0 (fi) | Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen | |
| BR9407869A (pt) | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose | |
| BR9508586A (pt) | Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| BR8900357A (pt) | Composicao e processo de tratamento de tecido e processo para a preparacao da dita composicao | |
| BR9600353A (pt) | Processo para melhoria da segurança de dispositivos cirúrgicos implantáveis fixados em tecido ósseo e dispositivo cirúrgico | |
| BR9006924A (pt) | Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos | |
| BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
| BR9610522A (pt) | Composição para lavagem do corpo e processo para o tratamento da pele | |
| BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
| BR9609780A (pt) | Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto | |
| BR9000990A (pt) | Composicao aquosa condicionadora de tecidos e processo para o tratamento de tecidos | |
| BR9002334A (pt) | Composicao de condicionamento de tecidos para uso na enxaguadura,e processo para tratar tecidos no ciclo de enxaguadura | |
| BR9707489A (pt) | Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico | |
| KR920700634A (ko) | 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물 | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
| BR9708607A (pt) | Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico | |
| BR8700022A (pt) | Formulacao pesticida para o tratamento de agua e processo para controlar pragas que vivem em agua | |
| BR9708459A (pt) | Sistema dispositivo implantável e processo para promover o crescimento em uma direção predeterminada de regenerado de tecido e uso do sistema e do dispositivo | |
| BR9912773A (pt) | Processo e aparelho para o tratamento tópico de tecido doente e processo para o tratamento de doenças em vasos do sistema circulatório | |
| BR9106377A (pt) | Composicao e processo para o tratamento topico de tecido lesado ou enfermo | |
| BR9710376A (pt) | Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |